BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18285546)

  • 1. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    French D; Hamilton LH; Mattano LA; Sather HN; Devidas M; Nachman JB; Relling MV;
    Blood; 2008 May; 111(9):4496-9. PubMed ID: 18285546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.
    Sherief LM; Beshir M; Raafat N; Abdelkhalek ER; Mokhtar WA; Elgerby KM; Soliman BK; Salah HE; Mokhtar GA; Kamal NM; ELsayed H; Zakaria M
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1700. PubMed ID: 34042331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Bond J; Adams S; Richards S; Vora A; Mitchell C; Goulden N
    Blood; 2011 Sep; 118(9):2632-3. PubMed ID: 21885611
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.
    Kawedia JD; Kaste SC; Pei D; Panetta JC; Cai X; Cheng C; Neale G; Howard SC; Evans WE; Pui CH; Relling MV
    Blood; 2011 Feb; 117(8):2340-7; quiz 2556. PubMed ID: 21148812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia.
    Karol SE; Yang W; Van Driest SL; Chang TY; Kaste S; Bowton E; Basford M; Bastarache L; Roden DM; Denny JC; Larsen E; Winick N; Carroll WL; Cheng C; Pei D; Fernandez CA; Liu C; Smith C; Loh ML; Raetz EA; Hunger SP; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Mattano LA; Relling MV
    Blood; 2015 Oct; 126(15):1770-6. PubMed ID: 26265699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia.
    den Hoed MA; Pluijm SM; Uitterlinden AG; Pieters R; van den Heuvel-Eibrink MM
    Mol Diagn Ther; 2016 Dec; 20(6):519-522. PubMed ID: 27365083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A
    Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
    Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the Relationship Between
    Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
    Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
    Liang XN; Xie L; Cheng JW; Tan Z; Yao J; Liu Q; Su W; Qin X; Zhao JM
    Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.
    Karol SE; Mattano LA; Yang W; Maloney KW; Smith C; Liu C; Ramsey LB; Fernandez CA; Chang TY; Neale G; Cheng C; Mardis E; Fulton R; Scheet P; San Lucas FA; Larsen EC; Loh ML; Raetz EA; Hunger SP; Devidas M; Relling MV
    Blood; 2016 Feb; 127(5):558-64. PubMed ID: 26590194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.
    Finkelstein Y; Blonquist TM; Vijayanathan V; Stevenson KE; Neuberg DS; Silverman LB; Vrooman LM; Sallan SE; Cole PD
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations.
    Yang W; Devidas M; Liu Y; Smith C; Dai Y; Winick N; Hunger SP; Loh ML; Raetz EA; Larsen EC; Carroll WL; Winter SS; Dunsmore KP; Mattano LA; Relling MV; Karol SE
    Blood; 2021 Mar; 137(11):1550-1552. PubMed ID: 33106839
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Levien MG
    Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia.
    Relling MV; Yang W; Das S; Cook EH; Rosner GL; Neel M; Howard S; Ribeiro R; Sandlund JT; Pui CH; Kaste SC
    J Clin Oncol; 2004 Oct; 22(19):3930-6. PubMed ID: 15459215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women.
    Jeon YJ; Kim YR; Lee BE; Choi YS; Kim JH; Shin JE; Rah H; Cha SH; Lee WS; Kim NK
    Thromb Haemost; 2013 Oct; 110(4):742-50. PubMed ID: 23903286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Badhiwala JH; Nayiager T; Athale UH
    Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia.
    ElHarouni D; Yassin D; Ali N; Gohar S; Zaky I; Adwan H; Sidhom I
    Front Oncol; 2018; 8():541. PubMed ID: 30533396
    [No Abstract]   [Full Text] [Related]  

  • 19. Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.
    Gagné V; Aubry-Morin A; Plesa M; Abaji R; Petrykey K; St-Onge P; Beaulieu P; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
    Pharmacogenomics; 2019 Nov; 20(17):1189-1197. PubMed ID: 31686588
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis.
    Gong LL; Fang LH; Wang HY; Peng JH; Si K; Zhu J; Han FF; Wang YH; Du GH; Pei LX; Liu LH
    Steroids; 2013 Apr; 78(4):401-8. PubMed ID: 23357434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.